AU2001259668A1 - Methods for testing compounds useful for treating diabetic complications - Google Patents

Methods for testing compounds useful for treating diabetic complications

Info

Publication number
AU2001259668A1
AU2001259668A1 AU2001259668A AU5966801A AU2001259668A1 AU 2001259668 A1 AU2001259668 A1 AU 2001259668A1 AU 2001259668 A AU2001259668 A AU 2001259668A AU 5966801 A AU5966801 A AU 5966801A AU 2001259668 A1 AU2001259668 A1 AU 2001259668A1
Authority
AU
Australia
Prior art keywords
methods
compounds useful
diabetic complications
treating diabetic
testing compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001259668A
Inventor
John Ansel
Cheryl Armstrong
James Nolan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institute for Pharmaceutical Discovery Inc
Original Assignee
INST PHARMACEUTICAL DISCOVERY
Institute for Pharmaceutical Discovery Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by INST PHARMACEUTICAL DISCOVERY, Institute for Pharmaceutical Discovery Inc filed Critical INST PHARMACEUTICAL DISCOVERY
Publication of AU2001259668A1 publication Critical patent/AU2001259668A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5082Supracellular entities, e.g. tissue, organisms
    • G01N33/5088Supracellular entities, e.g. tissue, organisms of vertebrates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/0004Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
AU2001259668A 2000-05-09 2001-05-09 Methods for testing compounds useful for treating diabetic complications Abandoned AU2001259668A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US20315100P 2000-05-09 2000-05-09
US60/203,151 2000-05-09
PCT/US2001/014952 WO2001085983A2 (en) 2000-05-09 2001-05-09 Methods for testing compounds useful for treating diabetic complications

Publications (1)

Publication Number Publication Date
AU2001259668A1 true AU2001259668A1 (en) 2001-11-20

Family

ID=22752724

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001259668A Abandoned AU2001259668A1 (en) 2000-05-09 2001-05-09 Methods for testing compounds useful for treating diabetic complications

Country Status (3)

Country Link
US (1) US20020012630A1 (en)
AU (1) AU2001259668A1 (en)
WO (1) WO2001085983A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10674043B2 (en) * 2016-07-08 2020-06-02 Hewlett-Packard Development Company, L.P. Color table compression
PL237474B1 (en) * 2017-05-04 2021-04-19 Wyzsza Szkola Medyczna W Bialymstoku New applications of 2-[(3Z)-6-fluoro-2-methyl-3-[(4-methylsulfinylphenyl) methylidene]inden-1-yl] acetic acid

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4717725A (en) * 1984-04-11 1988-01-05 Alcon Laboratories, Inc. Ophthalmic wound healing with aldose reductase inhibitors
US4600717A (en) * 1984-04-11 1986-07-15 Alcon Laboratories, Inc. Aldose reductase inhibitors useful in ophthalmic wound healing
US4751243A (en) * 1986-05-07 1988-06-14 American Home Products Corporation Tolrestat for wound healing
WO1999050268A2 (en) * 1998-03-31 1999-10-07 The Institutes For Pharmaceutical Discovery, Inc. Substituted indolealkanoic acids
TNSN99224A1 (en) * 1998-12-01 2005-11-10 Inst For Pharm Discovery Inc METHODS OF REDUCING GLUCOSE AND TRIGLYCERIDE LEVELS IN SERUM AND FOR ANTIGENESIS SUPPRESSION USING INDOLEALKANOIC ACIDS

Also Published As

Publication number Publication date
US20020012630A1 (en) 2002-01-31
WO2001085983A3 (en) 2002-10-03
WO2001085983A2 (en) 2001-11-15

Similar Documents

Publication Publication Date Title
AU2001231104A1 (en) Methods for treating diabetes
AU2001227966A1 (en) Methods for treating tumors
AU2001245283A1 (en) Methods for treating aneurysms
AU6213001A (en) Method for oxidizing hydrocarbons
AU2651701A (en) Method for introducing additives
AUPQ540900A0 (en) Apparatus for composting
AU2001255602A1 (en) Methods for treating bone tumors
AU2002210881A1 (en) Transdermal method
AU2001214778A1 (en) Method for preventing or treating postoperative ileus
AU2002225930A1 (en) Methods for treating phosphatide-containing mixtures
AU2001273609A1 (en) Process for treating wood
AU2001237939A1 (en) Methods for treating glaucoma
AU2001275085A1 (en) Methods, compounds and compositions for treating gout
AU2001289123A1 (en) Compounds and methods for diagnosing and treating amyloid-related conditions
AU2002211563A1 (en) Compounds useful for treating hypertriglyceridemia
AU2001291313A1 (en) Process for making 3-amino-2-chloro-4-methylpyridine
AU2001277938A1 (en) Method for treating angina
AU2002241670A1 (en) Method for treating glaucoma IB
AU5867901A (en) Method for detecting tumors
AU1112500A (en) Methods for inhibiting diabetic complications
AU2001259668A1 (en) Methods for testing compounds useful for treating diabetic complications
AU2002224842A1 (en) Method for binding compound elements
AU2002246912A1 (en) Receptor-binding compounds and methods for identifying them
AU2001288518A1 (en) Methods for treating tumors using sulfonyl compounds
AU2002220757A1 (en) Method for obtaining azaerythromycin